ANI Pharmaceuticals Inc ANIP Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

06:40 EDT 21 Jun 2017 | BioPortfolio Reports

ANI Pharmaceuticals Inc ANIP Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


ANI Pharmaceuticals Inc ANI formerly BioSante Pharmaceuticals Inc, is a specialty pharmaceutical company that develops, manufactures and markets pharmaceuticals. The company's product portfolio encompasses generic and branded tablets indicated for ulcerative colitis; osteoarthritis; rheumatoid arthritis; primary hypercholesterolemia; severe hypertriglyceridemia; arrhythmia; obsessivecompulsive disorder; social anxiety disorder; ulcerative proctitis; ulcerative proctosigmoiditis; bipolar disorder; glaucoma; metastatic prostate cancer; diarrhea; and pain. It caters to markets including oncolytics; complex formulations, hormones and steroids; and controlled substances. ANI also undertakes contract manufacturing of coated and noncoated capsules; oral dosage forms; liquid solution; topical liquids; suspension forms; and tablets. The company sells its products to wholesalers, group purchasing organizations, mail order houses in the US, and pharmacy retail outlets. ANI is headquartered in Baudette, Minnesota, the US.

ANI Pharmaceuticals Inc Key Recent Developments

May 04,2017: ANI Pharmaceuticals Reports First Quarter Results and YearToDate 2017 Highlights and Reaffirms Guidance
Mar 02,2017: ANI Pharmaceuticals Reports Full Year 2016 Results and Fourth Quarter Results and Provides 2017 Guidance
Jan 17,2017: ANI Announces Appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory Affairs
Nov 03,2016: ANI Pharmaceuticals Reports Record Third Quarter Results and YearToDate 2016 Highlights and Narrows Fullyear Guidance
Aug 04,2016: ANI Pharmaceuticals Reports Record Second Quarter Results and Increases Fullyear 2016 Guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: ANI Pharmaceuticals Inc ANIP Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125


More From BioPortfolio on "ANI Pharmaceuticals Inc ANIP Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125"

Quick Search


Relevant Topic

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...